Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2021-01-25 Share Issue/Capital Cha…
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Share Issue/Capital Change Classification · 1% confidence The document is very short (1913 characters) and contains the header 'RNS Number : 7703M'. It announces a 'Price Monitoring Extension' related to trading procedures on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or DLST), the most appropriate classification is the general regulatory filing fallback.
2021-01-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 0479M' and contains the standard boilerplate text referencing 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content itself is a 'TR-1: Standard form for notification of major holdings', detailing changes in voting rights held by BGF Investment Management Limited, crossing a threshold on 15/01/2021. This type of mandatory disclosure regarding significant changes in share ownership directly maps to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2021-01-18 English
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is very short (2697 characters) and its primary purpose is to announce *when* the company will release its interim results (Thursday, 25 March 2021). It does not contain the actual interim results or the detailed financial report itself. The text explicitly states 'Notice of Results' and details the future release date. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached qualifies as a Report Publication Announcement (RPA). The presence of the RNS Number and the RNS footer further confirms this is a regulatory announcement about a future report release.
2021-01-18 English
Result of AGM
AGM Information Classification · 1% confidence The document explicitly states it is announcing the 'Result of AGM' (Annual General Meeting). It details that 'all resolutions proposed were duly passed' and provides a table showing the proxy voting results for specific resolutions, such as receiving the Annual Report, approving the Remuneration Report, and re-appointing directors. This content directly corresponds to the definition of AGM Information (AGM-R). Although it mentions the Annual Report (Resolution 1), the document itself is the announcement of the meeting's outcome, not the full 10-K report.
2020-12-30 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement from the London Stock Exchange, indicated by the 'RNS Number' and the concluding boilerplate text mentioning RNS and the FCA. The content itself is a 'TR-1: Standard form for notification of major holdings'. This form reports a change in the percentage of voting rights held by a shareholder (BGF Investment Management Limited) in the issuer (Genedrive PLC), crossing a notification threshold. This type of filing, which reports changes in significant share ownership, directly corresponds to the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-12-23 English
Response to new COVID strain
Environmental & Social Information Classification · 1% confidence The document begins with 'RNS Number' and is distributed via 'RNS, the news service of the London Stock Exchange,' which is explicitly mentioned as the Primary Information Provider regulated by the FCA. The content is a brief, timely announcement regarding the company's COVID-19 test's ability to detect new virus strains. This format—a short, regulatory news update disseminated through the official channel—fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category (like 10-K, ER, or IR). Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short (3385 chars), but it is an announcement of operational/product status, not an announcement of a report publication (RPA).
2020-12-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.